Abstract:Objective To explore the dose- and time-responses of BPCBG on the decorporation of uranium and its protective effects for uranium-induced kidney injury in rats. Methods Sprague-Dawley (SD) male rats were randomly divided into 4 -7 groups:normal control group,uranium poisoning group,different doses of BPCBG groups and DTPA-CaNa3 group. Rats in chelating agents-treated groups were either injected intramuscularly with 60,120 and 600 μmol/kg of BPCBG or 120 and 600 μmol/kg of DTPA-CaNa3 immediately after intraperitoneal injection of uranyl acetate dihydrate,or injected with 120 μmol/kg of BPCBG 0.5,2 h before or 0,0.5,1 and 2 h after injection of uranium. Uranium poisoning group rats were injected with normal saline after intraperitoneal injection of uranyl acetate dihydrate,and the normal control group rats were merely injected with normal saline. The uranium content in urine,kidney and femurs were detected 24 h after chelator injections by ICP-MS method.After injecting a dose of 500 μg uranyl acetate dihydrate,rats were injected with 600 μmol/kg of BPCBG or 1200 μmol/kg of DTPA-CaNa3. Histopathological changes in the kidney and serum creatinine and urea nitrogen were examined 48 h after chelator administration.Results Prompt injections of BPCBG resulted in 37％ -61％ ( t =2.22,4.43,5.80,P ＜ 0.05 ) increase in 24 h-urinary uranium excretion,and significantly decreased the levels of uranium in kidney and bone by 59％ -69％ (t=3.33,5-59,4-53,P＜0.01) and 14％ -58％ (t =2.15,8.70,9.10,P ＜ 0.05 ) respectively in a dose-dependent manner. BPCRG injection obviously reduced the severity of the uranium-induced histological alterations in the kidney,which was in parallel with the amelioration noted in serum indicators,serum creatinine and urea nitrogen,of uranium nephrotoxicity.Advanced 0.5 h or delayed 0.5 and 1 h administrations of BPCBG were effective in 24 h-urinary uranium excretion ( advanced 0.5 h:t =4.34,delayed 0.5 h:t =3.35,P ＜ 0.05 ),decreasing accumulation of kidney uranium ( t =5.75,7.74,5.87,P ＜ 0.05 ) and accumulation of hone uranium (t =6.43,5.222,2.60,P ＜0.05),but the efficacy decreased with the interval time between uranium and BPCBG injection. Although DTPA-CaNa3 markedly reduced uranium retention in kidney (120,600 μmol/kg,t =2.28,3.35,P ＜ 0.05 ),its efficacy in uranium removal was significantly lower than that of BPCBG,and it had no protective effects against uranium-induced nephrotoxicity.Conclusions BPCBG can effectively decorporate uranium from rats and protect against uranium-induced kidney injury of rats.

Efficacy of Chelator Cbmida-Cana2 for the Removal of Uranium and Protection Against Uranium-Induced Cell Damage in Human Renal Proximal Tubular Cells

Efficacy of a novel chelator BPCBG for removing uranium and protecting against uranium-induced renal cell damage in rats and HK-2 cells.

[Effect of the chelator BPCBG on the decorporation of uranium in vivo and uranium-induced damage of human renal tubular epithelial cells in vitro]

Protective effect of urolithin a on cisplatin-induced nephrotoxicity in mice via modulation of inflammation and oxidative stress

Protective effects of ion-imprinted chitooligosaccharides as uranium-specific chelating agents against the cytotoxicity of depleted uranium in human kidney cells

A Mitochondria-Targeted Heptamethine Indocyanine Small Molecular Chelator for Attenuating Uranium Nephrotoxicity

The Chelator BPCBG Decorporates Uranium and Protects Against Uranium-Induced Kidney Injury in Rats

Detoxication Effect of Water-Soluble Imprinted Cross-Linked Chitosan on Depleted Uranium Induced Toxicity to Renal Cells

Competitive combination with uranium (Ⅵ) between chelating agent and metallothionein

Decorporating Efficacy of Catecholaminocarboxylate Chelating Agents for Thorium-234 and Protective Effects on Associated Radiation Injury.

Immobilization of In-Situ Formed Ni(OH)2 Nanoparticles in Chitosan Beads for Efficient Removal of U(VI) from Aqueous Solutions

Protective effects of Polygonatum kingianum polysaccharides and aqueous extract on uranium-induced toxicity in human kidney (HK-2) cells

Catechol amide derivatized polyhydroxylated fullerene as potential chelating agents of radionuclides: Synthesis, reactive oxygen species scavenging, and cytotoxic studies

Influence of EDTA on the Interaction Between U(VI) and Calcite

Enhancement of Repeated Applications of Chelates on Phytoremediation of Uranium Contaminated Soil by Macleaya Cordata.

Macroporous and ultralight polyethyleneimine-grafted chitosan/nano-TiO 2 foam as a novel adsorbent with antibacterial activity for the efficient U(VI) removal

Human Umbilical Cord-Derived Mesenchymal Stem Cells and Human Cord Blood Mononuclear Cells Protect Against Cisplatin-Induced Acute Kidney Injury in Rat Models.

Macroporous and ultralight polyethyleneimine-grafted chitosan/nano-TiO2 foam as a novel adsorbent with antibacterial activity for the efficient U(VI) removal.

Protective Effects of Chelating Agents of Catechols Amino Carboxylic Acid Type on Radiation Injury Induced by Radiothorium in Mice II.delayed Administration

1-(2-Hydroxyethoxy)Methyl-2-Methyl-3-Hydroxyl-4-Pyridinone: ATargeted, Bifunctional Chelating Agent for Potential Uranic Detoxification in the Kidney

Linear Β-Cyclodextrin Polymer Functionalized Multiwalled Carbon Nanotubes As Nanoadsorbent for Highly Effective Removal of U(VI) from Aqueous Solution Based on Inner-Sphere Surface Complexation